ClinConnect ClinConnect Logo
Search / Trial NCT06745791

Clinical Validation of BoneMRI in the Spine

Launched by MRIGUIDANCE B.V. · Dec 17, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Medical Device Software Synthetic Ct Mri Sequence

ClinConnect Summary

This clinical trial is studying a new imaging technology called BoneMRI, which uses MRI (Magnetic Resonance Imaging) to create detailed pictures of bones in the spine. Unlike traditional MRI, BoneMRI can provide information similar to what a CT scan offers, helping doctors see the structure of the bones more clearly. The trial aims to validate this technology for use across the entire spine, ensuring it provides accurate and reliable images, regardless of the type of MRI machine used.

To participate in this study, you need to be at least 12 years old and have a doctor's recommendation for an MRI or CT scan of your spine. You should be eligible for both types of scans and be able to give written consent. Unfortunately, if you are pregnant, have certain mental health conditions, or feel extremely claustrophobic, you may not be able to join the trial. If you do participate, you can expect a straightforward process that combines both MRI and CT imaging, allowing for better diagnosis and treatment planning without the risks associated with radiation exposure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 12 years old
  • Indication for diagnostic MRI of the spine
  • Indication for diagnostic CT of the spine
  • Eligible for MRI
  • Eligible for CT
  • Written informed consent
  • Exclusion Criteria:
  • Pregnancy
  • History of (psychiatric) disorder which causes the patient to be incompetent to make a thought-out decision
  • claustrophobia
  • \>3 months between CT and MRI scan

About Mriguidance B.V.

mriguidance b.v. is a pioneering medical technology company specializing in advanced imaging solutions for the healthcare sector. Focused on enhancing patient outcomes, the company develops innovative MRI-guided systems and software that improve the precision of diagnostics and treatment planning. With a commitment to research and development, mriguidance b.v. collaborates with leading medical institutions to advance clinical practices and facilitate the integration of cutting-edge imaging technologies into routine care. Through its rigorous clinical trials and adherence to regulatory standards, mriguidance b.v. aims to revolutionize the field of medical imaging and contribute to the ongoing evolution of personalized medicine.

Locations

Marseille, , France

Gent, , Belgium

Rotterdam, , Netherlands

Utrecht, , Netherlands

St. Gallen, , Switzerland

Leuven, , Belgium

Amsterdam, , Netherlands

Tilburg, , Netherlands

Sint Niklaas, , Belgium

Leiden, , Netherlands

Patients applied

0 patients applied

Trial Officials

Peter R Seevinck, dr. ir.

Study Director

iCEO, Founder

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported